(lp0
S'Stock Volatility Risk Alert: iCAD Inc Stock Volatility Hits A Towering High CML News - 21 hours ago Before we dive into any analysis we simply note that iCAD Inc  has seen its stock price whip around at a towering high level.'
p1
aS'4.75 MarketWatch - Nov 1, 2009 ICad Inc. says to use $3.3M to pay down debt. 1:12 p.m. Dec. 15, 2004. - Carla Mozee. ICad Inc. reports $8.4M private placement.'
p2
aS"Connecture Inc versus iCAD Inc Head to Head Compare CML News - Mar 25, 2017 Connecture Inc has a higher fundamental rating than iCAD Inc which has an impact on the head-to-head comparison. The CML Star Rating is an objective, quantifiable measure of a company's operating and financial condition."
p3
aS'iCAD Showcases Targeted, Non-Surgical Non-Melanoma Skin Cancer Treatment at ... PR Newswire  - Mar 3, 2017 NASHUA, N.H. and ORLANDO, Fla., March 3, 2017 /PRNewswire/ --  - iCAD, Inc. , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of&nbsp;...'
p4
aS"Traders Checklist Stock: iCAD, Inc.'s  Is stories - Mar 27, 2017 iCAD, Inc.'s  witnessed a loss of -1.80% in recent trading period with closing price of $ 4.37. The company's last traded volume of 0.07 million shares was more it's an average volume of 0.04 million shares."
p5
aS'iCAD, Inc.  announced PowerLook Tomo Detection received ... Benchmark Monitor - 17 hours ago iCAD, Inc.  announced that PowerLook Tomo Detection received Premarket Approval  from the U.S. Food and Drug Administration .'
p6
aS'iCAD, Inc. Withdraws 2015 Financial Guidance Due to General Reimbursement ... GlobeNewswire  - May 27, 2015 NASHUA, N.H., May 27, 2015  -- iCAD, Inc.  announced today that it is withdrawing its full year 2015 financial guidance due to general uncertainty related to reimbursement for non-melanoma skin cancer in the United&nbsp;...'
p7
aS"Trading Options During Earnings in iCAD Inc  CML News - Mar 20, 2017 We're going to examine buying and selling out of the money strangles in iCAD Inc and find out once and for all what the winning trades have been during earnings releases."
p8
aS"Stocks in Analyst's Viewfinder: Hemispherx Biopharma, Inc.  iCAD, Inc ... Rives Journal - Mar 27, 2017 Hemispherx Biopharma, Inc.  shares have been labeled a top pick by Beta Research as it meets the A+ criteria outlined by the firm."
p9
aS"Is iCAD Inc's  Balance Sheet Strong Enough To Weather A Storm? Simply Wall St - Mar 8, 2017 In any company, including iCAD Inc  which has zero-debt on its balance sheet, there are well known benefits of including debt in the capital structure, primarily a lower cost of capital - due to debtholders' higher claim on assets in the ..."
p10
a.